Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide and Vincristine in Treatment Progress, Relapse, and Refractory Solid Tumors in Children

NCT04213612 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT04213612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04213612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide and Vincristine in Treatment Progress, Relapse, and Refractory Solid Tumors in Children
Lead sponsor
Sun Yat-sen University
Phase
Phase 1
Overall status
Unknown status
Start date
December 30, 2019
Completion date
November 30, 2020
Enrollment
21 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

unrecognized condition